Hery Chung

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study

Hery Chung, Angélica Fierro, C. David Pessoa‐Mahana · PLoS ONE · 2019 · 70 citations · Full text

Drug Target, Molecular Biology, Cannabidiol Binding +16

Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease

Julio Rodríguez-Lavado, Carlos Gallardo‐Garrido, Michael Mallea et al. · European Journal of Medicinal Chemistry · 2020 · 28 citations · Full text

Molecular Pharmacology, Biochemistry, Dual Ache +9

Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor

Javier Romero‐Parra, Hery Chung, Ricardo A. Tapia et al. · European Journal of Pharmaceutical Sciences · 2017 · 24 citations

Cannabis Use, Medicinal Chemistry, Drug Target +10

Synthesis and biological evaluation of potential acetylcholinesterase inhibitors based on a benzoxazine core

Claudio Méndez‐Rojas, Gabriel Quiroz, Mario Faúndez et al. · Archiv der Pharmazie · 2018 · 16 citations · Full text

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands

Marcos Lorca, Yudisladys Valdes, Hery Chung et al. · International Journal of Molecular Sciences · 2019 · 16 citations · Full text